Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D M Reese

Showing results (21-30 of 28) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 28 results.
American Journal of Clinical Pathology|August 8, 2001
HER2 protein expression and gene amplification in androgen-independent prostate cancerD M Reese, E J Small, G Magrane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factorE J Small, D M Reese, B Um, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cellsE J Small, P Fratesi, D M Reese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancerE J Small, M W Frohlich, R Bok, et al.
Oncogene|June 15, 1995
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cellsR J Pietras, J Arboleda, D M Reese, et al.
Nature Genetics|July 1, 1996
BRCA1 protein products: antibody specificityC A Wilson, M N Payton, S K Pekar, et al.
Oncogene|January 9, 1997
Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11bC A Wilson, M N Payton, G S Elliott, et al.
Clinical Pharmacology and Therapeutics|May 6, 2017
Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening DiseasesJ S Prescott, P A Andrews, R W Baker, et al.
Pageof 3

Showing results (21-30 of 28) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 28 results.
American Journal of Clinical Pathology|August 8, 2001
HER2 protein expression and gene amplification in androgen-independent prostate cancerD M Reese, E J Small, G Magrane, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 3, 1999
Therapy of advanced prostate cancer with granulocyte macrophage colony-stimulating factorE J Small, D M Reese, B Um, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 1, 2000
Immunotherapy of hormone-refractory prostate cancer with antigen-loaded dendritic cellsE J Small, P Fratesi, D M Reese, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 31, 2000
Prospective trial of the herbal supplement PC-SPES in patients with progressive prostate cancerE J Small, M W Frohlich, R Bok, et al.
Oncogene|June 15, 1995
HER-2 tyrosine kinase pathway targets estrogen receptor and promotes hormone-independent growth in human breast cancer cellsR J Pietras, J Arboleda, D M Reese, et al.
Nature Genetics|July 1, 1996
BRCA1 protein products: antibody specificityC A Wilson, M N Payton, S K Pekar, et al.
Oncogene|January 9, 1997
Differential subcellular localization, expression and biological toxicity of BRCA1 and the splice variant BRCA1-delta11bC A Wilson, M N Payton, G S Elliott, et al.
Clinical Pharmacology and Therapeutics|May 6, 2017
Evaluation of Therapeutics for Advanced-Stage Heart Failure and Other Severely-Debilitating or Life-Threatening DiseasesJ S Prescott, P A Andrews, R W Baker, et al.
Pageof 3